已收录 268921 条政策
 政策提纲
  • 暂无提纲
Mid-term efficacy and safety of Escherichia coli -derived rhBMP-2/hydroxyapatite carrier in lumbar posterolateral fusion: a randomized, multicenter study
[摘要] Purpose This study aimed to evaluate the mid-term efficacy and safety of Escherichia coli-derived bone morphogenetic protein-2 (E.BMP-2)/hydroxyapatite (HA) in lumbar posterolateral fusion (PLF).
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 骨科学
[关键词] BMP-2;Bone substitutes;\n E. coli\n;Hydroxyapatite;Posterolateral fusion;Iliac bone graft [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文